Thiopurines in Crohn's disease, is there something new?

Author： Miheller Pal Lakatos Peter Laszlo

ISSN： 1742-5255

Source： Expert Opinion on Drug Metabolism and Toxicology, Vol.6, Iss.12, 2010-12, pp. : 1505-1514

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

New targets for Crohn's disease

By Pestell K.

Trends in Pharmacological Sciences, Vol. 22, Iss. 7, 2001-07 ,pp. : 342-342

Elsevier

Access to resources Recommend Favorite

Pharmacogenetics of Thiopurines in Inflammatory Bowel Disease

Current Pharmaceutical Design, Vol. 16, Iss. 2, 2010-01 ,pp. : 145-154

Bentham Science Publishers

Access to resources Recommend Favorite

New insights into the biological therapy of Crohn’s disease

By Hassan Cesare Zullo Angelo Campo Salvatore MA Morini Sergio

Expert Opinion on Therapeutic Patents, Vol. 15, Iss. 4, 2005-04 ,pp. : 409-419

Informa Healthcare

Access to resources Recommend Favorite

Thiopurines for Inflammatory Bowel Disease: Role of Pharmacogenetics

JOURNAL OF PHARMACY PRACTICE AND RESEARCH, Vol. 35, Iss. 3, 2005-09 ,pp. : 213-215

John Wiley & Sons Inc

Access to resources Recommend Favorite

New alternatives for the treatment of Crohn's disease?

Inpharma, Vol. 1, Iss. 1241, 2000-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite